logo
Select company
Select metric
16.02%Gross Profits to Assets
VS
Market
50
Sector
57
Industry
76
History
79
$ 9.84Close
$ 8.24 - $ 28.14 52-Week Range
Ticker Information

Ticker

NRIX

Company Name

NURIX THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NURIX THERAPEUTICS INC - Gross Profits to Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRIX - GPA Historical data
DateTotal AssetsGross ProfitGross Profits to Assets
9/30/2025$ 522.47M$ 83.69M16.02%
6/30/2025$ 591.55M$ 88.38M14.94%
3/31/2025$ 615.04M$ 56.42M9.17%
12/31/2024$ 669.34M$ 54.55M8.15%
9/30/2024$ 513.6M$ 56.42M10.99%
6/30/2024$ 511.03M$ 62.3M12.19%
3/31/2024$ 312.67M$ 80.89M25.87%
12/31/2023$ 355.6M$ 76.99M21.65%
9/30/2023$ 308.19M$ 68.61M22.26%
6/30/2023$ 350.62M$ 60.94M17.38%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NURIX THERAPEUTICS INC's latest trailing twelve months (TTM) GPA stands at 4.5%.
  • Over the past 5 years, NURIX THERAPEUTICS INC's average GPA has been 11.92%.
  • The median GPA for NURIX THERAPEUTICS INC during this period was 9.81%
  • NURIX THERAPEUTICS INC reached its highest GPA over the past 5 years at 25.87%.
  • The lowest GPA recorded by NURIX THERAPEUTICS INC in the same timeframe 4.42%

NURIX THERAPEUTICS INC's GPA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GPA Benchmarks
CompanyGPA
SNDX : SYNDAX PHARMACEUTICALS INC 12.61%URGN : UROGEN PHARMA LTD 39.97%TBPH : THERAVANCE BIOPHARMA INC 18.12%KURA : KURA ONCOLOGY INC 12.2%GYRE : GYRE THERAPEUTICS INC 64.21%ZVRA : ZEVRA THERAPEUTICS INC 17.41%CRMD : CORMEDIX INC 45.99%NAGE : NIAGEN BIOSCIENCE INC 80.85%SAGE : SAGE THERAPEUTICS INC 14.91%EYPT : EYEPOINT PHARMACEUTICALS INC 16.4%

Definition of Gross Profits to Assets

[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
GP / Assets
(=) GPA
GPA for NURIX THERAPEUTICS INC is calculated as follows: GP [ $ 17.82M ] / Assets [ $ 396.34M ]
(=) GPA [ 4.5% ]

NRIX - Gross Profits to Assets, Last 5 years

4.42%

Minimum

Jun 30, 2021

25.87%

Maximum

Mar 31, 2024

11.92%

Average

9.81%

Median

GPA Benchmark Analysis

The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.16% with a standard deviation of 19.95%.
The following table provides additional summary stats:
GPA in the Market:
filtered constituents4.13K
min-50.32%
max83.98%
average20.16%
median15.35%
std19.95%